Literature DB >> 8418277

Joint uptake and body distribution of a technetium-99m-labeled anti-rat-CD4 monoclonal antibody in rat adjuvant arthritis.

R W Kinne1, W Becker, G Simon, G Paganelli, E Palombo-Kinne, A Wolski, S Bloch, A Schwarz, F Wolf, F Emmrich.   

Abstract

Joint uptake and body distribution of a 99mTc-labeled monoclonal antibody (Mab) to the rat CD4 molecule (W3/25; IgG1) were investigated after intravenous injection in normal rats and in animals with experimentally induced adjuvant arthritis. An isotype-matched Mab with irrelevant specificity (anti-human carcino-embryonic-antigen) was used as control. A 4 hr sequential gamma-camera imaging revealed that both anti-CD4 and control Mab accumulated to a higher degree in arthritic than in normal ankle joints; the accumulation was comparable for the two Mabs. In contrast to the inflamed joints, a specific accumulation of the anti-CD4 Mab was found in organs rich in CD4-positive cells, i.e. spleen, bone marrow and lymph nodes, as assessed by direct well counter measurements 16 hr after injection. The control Mab displayed no preferential organ accumulation in either normal or diseased animals. These results indicate that a specific accumulation of anti-CD4 Mabs occurs in CD4-positive-cell-rich tissues in both normal and diseased animals and that immunoglobulins accumulate preferentially in inflamed joints regardless of their antibody specificity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8418277

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  6 in total

1.  Current imaging strategies in rheumatoid arthritis.

Authors:  Merissa N Zeman; Peter Jh Scott
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28

2.  Local versus systemic anti-tumour necrosis factor-α effects of adalimumab in rheumatoid arthritis: pharmacokinetic modelling analysis of interaction between a soluble target and a drug.

Authors:  David Stepensky
Journal:  Clin Pharmacokinet       Date:  2012-07-01       Impact factor: 6.447

3.  Imaging rheumatoid arthritis joints with technetium-99m labelled specific anti-CD4- and non-specific monoclonal antibodies.

Authors:  R W Kinne; W Becker; J Schwab; A Schwarz; J R Kalden; F Emmrich; G R Burmester; F Wolf
Journal:  Eur J Nucl Med       Date:  1994-02

4.  Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen-induced arthritis: influence on T helper cell activation.

Authors:  D Pohlers; K Nissler; O Frey; J Simon; P K Petrow; R W Kinne; R Bräuer
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

Review 5.  New agents for scintigraphy in rheumatoid arthritis.

Authors:  M H de Bois; E K Pauwels; F C Breedveld
Journal:  Eur J Nucl Med       Date:  1995-11

Review 6.  Molecular imaging of rheumatoid arthritis: emerging markers, tools, and techniques.

Authors:  Stéphanie Put; René Westhovens; Tony Lahoutte; Patrick Matthys
Journal:  Arthritis Res Ther       Date:  2014-04-15       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.